advertisement

WGC-2021

Expert Opinion on Therapeutic Patents 17

Showing records 1 to 17 | Display all abstracts in Expert Opinion on Therapeutic Patents

82273 Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
Bonardi A
Expert Opinion on Therapeutic Patents 2019; 29: 753-759
82395 Diagnostic markers for glaucoma: a patent and literature review (2013-2019)
Bua S
Expert Opinion on Therapeutic Patents 2019; 29: 829-839
82315 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018)
Angeli A
Expert Opinion on Therapeutic Patents 2019; 29: 793-803
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82535 Rho-kinase inhibitors in the management of glaucoma
Berrino E
Expert Opinion on Therapeutic Patents 2019; 29: 817-827
82163 Novel therapies for glaucoma: a patent review (2013-2019)
Guglielmi P
Expert Opinion on Therapeutic Patents 2019; 29: 769-780
82353 Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019)
Nocentini A
Expert Opinion on Therapeutic Patents 2019; 29: 805-815
82535 Rho-kinase inhibitors in the management of glaucoma
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 817-827
82353 Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019)
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 805-815
82273 Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 753-759
82163 Novel therapies for glaucoma: a patent review (2013-2019)
Carradori S
Expert Opinion on Therapeutic Patents 2019; 29: 769-780
82395 Diagnostic markers for glaucoma: a patent and literature review (2013-2019)
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 829-839
82315 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018)
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 793-803
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Altamimi ASA
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82163 Novel therapies for glaucoma: a patent review (2013-2019)
Campestre C
Expert Opinion on Therapeutic Patents 2019; 29: 769-780
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Carta F
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82163 Novel therapies for glaucoma: a patent review (2013-2019)
Poce G
Expert Opinion on Therapeutic Patents 2019; 29: 769-780

Issue 20-4

Select Issue


advertisement

WGW-2021